Skip to content

Effect of gum treatment in hypertensive patients

Effect of non-surgical periodontal Treatment in patients with periodontitis and Refractory Arterial Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9d78qy
Enrollment
Unknown
Registered
2019-11-19
Start date
2019-12-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

The 26 patients will receive periodontal treatment by non-surgical periodontal therapy, from the oral hygiene instruction, which will receive information on which brush is best for their needs, flossi
Other
E06.721.189.350

Sponsors

Faculdade de Odontologia de Araçatuba FOA
Lead Sponsor
Faculdade de Odontologia de Araçatuba FOA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients over 35 years old; Have at least 12 teeth present; Diagnosis of generalized periodontitis according to periodontal classification: insertion loss in 2 non-adjacent interproximal sites, clinical insertion loss (CIN) greater than or equal to 3mm in 2 teeth, except for: gingival recession, dental caries, endoperiodontal injury, occurrence root fracture, presence of loss of insertion in the distal face of a second molar and associated with poor positioning or extraction of the third molar; a gingival condition would be described as localized when less than 30% of the teeth are affected; greater than 30% of teeth are affected by periodontal disease; Patients diagnosed with major refractory arterial hypertension equal to 140 and / or 90mmHg.

Exclusion criteria

Exclusion criteria: Smokers or former smokers less than 12 months old; Patient with anemia; Active cancer patient; Patient with blood disorders; Pregnancy; Patient with chronic kidney disease; Patient with decompensated Type II Diabetes Mellitus; Bacterial endocarditis; Having received some kind of prior periodontal therapy; Patient using any medication such as antibiotic or anti-inflammatory and systemic conditions that affect the progression or periodontal treatment; Patient undergoing chemotherapy and / or head and neck radiotherapy.

Design outcomes

Primary

MeasureTime frame
Improvement in periodontal clinical parameters such as clinical insertion level, bleeding on probing and probing depth, verified through probing depth, after intervention

Secondary

MeasureTime frame
Reduction in serum levels of inflammatory mediators through blood tests and systemic arterial hypertension measured by the pressure device, analyzes performed after the intervention.

Countries

Brazil

Contacts

Public ContactLetícia Theodoro

Faculdade de Odontologia de Araçatuba FOA

leticia.theodoro@unesp.br+55 (18) 3636-2860

Outcome results

None listed

Source: REBEC (via WHO ICTRP)